BRAFV600E Mutation and Its Association with Clinicopathological Features of Colorectal Cancer: A Systematic Review and Meta-Analysis
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
BRAFV600E Mutation and Its Association with Clinicopathological Features of Colorectal Cancer: A Systematic Review and Meta-Analysis
Authors
Keywords
-
Journal
PLoS One
Volume 9, Issue 3, Pages e90607
Publisher
Public Library of Science (PLoS)
Online
2014-03-04
DOI
10.1371/journal.pone.0090607
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BRAF-mutated, Microsatellite-stable Adenocarcinoma of the Proximal Colon
- (2012) Reetesh K. Pai et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Influence ofKRASmutation status in metachronous and synchronous metastatic colorectal adenocarcinoma
- (2012) Jeffrey S. Rose et al. CANCER
- KRASp.G13D mutation and codon 12 mutations are not created equal in predicting clinical outcomes of cetuximab in metastatic colorectal cancer
- (2012) Chen Mao et al. CANCER
- BRAF Mutation Status and Survival after Colorectal Cancer Diagnosis According to Patient and Tumor Characteristics
- (2012) A. I. Phipps et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- BRAF mutations in melanoma and colorectal cancer: A single oncogenic mutation with different tumour phenotypes and clinical implications
- (2012) F. Sclafani et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Concordance in KRAS and BRAF mutations in endoscopic biopsy samples and resection specimens of colorectal adenocarcinoma
- (2012) L.C. Krol et al. EUROPEAN JOURNAL OF CANCER
- Survey of KRAS, BRAF and PIK3CA mutational status in 209 consecutive Italian colorectal cancer patients
- (2012) Cristina Bozzao et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
- BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer
- (2011) T Yokota et al. BRITISH JOURNAL OF CANCER
- Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer
- (2011) Ben Tran et al. CANCER
- Predictive and Prognostic Roles of BRAF Mutation in Stage III Colon Cancer: Results from Intergroup Trial CALGB 89803
- (2011) S. Ogino et al. CLINICAL CANCER RESEARCH
- Impact ofKRASandBRAFGene Mutation Status on Outcomes From the Phase III AGITG MAX Trial of Capecitabine Alone or in Combination With Bevacizumab and Mitomycin in Advanced Colorectal Cancer
- (2011) Timothy J. Price et al. JOURNAL OF CLINICAL ONCOLOGY
- Review of Histopathological and Molecular Prognostic Features in Colorectal Cancer
- (2011) Ola Marzouk et al. Cancers
- The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients
- (2010) A. Fariña-Sarasqueta et al. ANNALS OF ONCOLOGY
- Dietary, lifestyle and clinicopathological factors associated with BRAF and K-ras mutations arising in distinct subsets of colorectal cancers in the EPIC Norfolk study
- (2010) Adam Naguib et al. BMC CANCER
- Smoking, Gender, and Ethnicity Predict Somatic BRAF Mutations in Colorectal Cancer
- (2010) L. S. Rozek et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Is BRAF Mutation Associated with Interval Colorectal Cancers?
- (2010) Aasma Shaukat et al. DIGESTIVE DISEASES AND SCIENCES
- Optimizing targeted therapeutic development: Analysis of a colorectal cancer patient population with the BRAFV600E mutation
- (2010) Jeanne Tie et al. INTERNATIONAL JOURNAL OF CANCER
- Prognostic and Predictive Biomarkers in Resected Colon Cancer: Current Status and Future Perspectives for Integrating Genomics into Biomarker Discovery
- (2010) S. Tejpar et al. ONCOLOGIST
- Microsatellite instability,MLH1promoter methylation, andBRAFmutation analysis in sporadic colorectal cancers of different ethnic groups in Israel
- (2009) Alex Vilkin et al. CANCER
- Somatic alterations, metabolizing genes and smoking in rectal cancer
- (2009) Karen Curtin et al. INTERNATIONAL JOURNAL OF CANCER
- Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial
- (2009) Arnaud D. Roth et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular Basis of Colorectal Cancer
- (2009) Sanford D. Markowitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ethnicity and Risk for Colorectal Cancers Showing Somatic BRAF V600E Mutation or CpG Island Methylator Phenotype
- (2008) D. R. English et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- BRAF mutation is associated with the CpG island methylator phenotype in colorectal cancer from young patients
- (2008) Pei Woon Ang et al. CANCER LETTERS
- Prognostic Significance of Defective Mismatch Repair and BRAF V600E in Patients with Colon Cancer
- (2008) A. J. French et al. CLINICAL CANCER RESEARCH
- Mutations in the RAS-MAPK, PI(3)K (phosphatidylinositol-3-OH kinase) signaling network correlate with poor survival in a population-based series of colon cancers
- (2008) Ludovic Barault et al. INTERNATIONAL JOURNAL OF CANCER
- Mutations ofKRASandBRAFin Primary and Matched Metastatic Sites of Colorectal Cancer
- (2008) Salvatore Artale et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search